IDBS ELN Powers World Class Preclinical Research at the UCT

IDBS has announced that the University of Cape Town (UCT) Drug Discovery and Development Centre, H3-D (http://www.h3-d.uct.ac.za/), is using the BioBook Electronic Laboratory Notebook (ELN) to store, manage and analyze its Drug Metabolism and Pharmacokinetic (DMPK) data.

Aligning itself with international standards in drug discovery, H3-D benefits from BioBook’s ability to consolidate assay results in one place, improving workflow and accelerating preclinical research.

“BioBook helps us undertake world class research from right here in South Africa. It is an exciting step for us as we are not only working faster but we are doing so without compromising on quality. Our confidence in our data continues to grow every day,” said Dr Nyaradzo T.L Chigorimbo-Tsikiwa, a postdoctoral fellow within H3-D.

Chigorimbo-Tsikiwa continued, “Having worked with BioBook previously, I’m confident in its abilities to provide us with the efficiency and traceability that we require in our fast moving environment.”

BioBook is currently being rolled out across H3-D. Users are able to track research projects and manage the large volumes of data associated with individual assays.

Analysis is completed within the system rather than relying on Microsoft Excel for data handling.

Working in this efficient way minimizes the risk of human error and enables H3-D to advance it’s drug discovery on a global scale with conviction in its research findings.

Neil Kipling, CEO and Founder of IDBS said, “The world’s leading academic institutions are now taking advantage of industrial informatics platforms like BioBook. Our ELN significantly improves workflow and boosts research productivity by up to 30%. It also makes collaboration easier and enables better decision making. This new relationship with UCT demonstrates our commitment to providing global academia with modern informatics technologies which can revolutionize academic R&D.”

BioBook is a flexible, automated solution which dramatically reduces time to market in late stage discovery, pharmacology and preclinical R&D.

It integrates with legacy data software such as laboratory information management systems (LIMS) and combines data imported from laboratory instruments to keep all research in one secure environment.

RELATED ARTICLES

The microfluidic device with interlinking modules containing human-derived heart, liver, skeletal muscle and nervous system cells was able to maintain cellular viability and record cellular function in real-time for 28 days.

Skin cells taken from patients with a rare genetic disorder are up to ten times more sensitive to damage from ultraviolet A radiation in laboratory tests, than those from a healthy population, according to new research from the University of Bath.